USP24 suppresses T cell anti-tumor activity by enhancing the stability of the PD-1 protein

被引：0
|
作者：
Hsieh, Hung-Chia
Hung, Jan-Jong
Wang, Yi-Ching
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB445
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PD-1 directly suppresses macrophage metabolism to restrict anti-tumor immunity in an obesity-cancer connection
    Bader, Jackie
    Rathmell, Jeffrey
    CANCER RESEARCH, 2024, 84 (06)
  • [22] Targeting metabolic vulnerabilities of MDSCs to enhance the anti-tumor activity of PD-1 blockade in melanoma
    Zheng, B.
    Kim, S.
    Li, M.
    Trousil, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S137 - S137
  • [23] Anti-tumor activity of cisplatin is enhanced by PD-1 blockade in preclinical models of head and neck squamous cell carcinoma
    Tran, Linda
    Allen, Clint T.
    Park, So-Jin
    Xiao, Roy
    Van Waes, Carter
    Schmitt, Nicole C.
    CANCER RESEARCH, 2017, 77
  • [24] The PARK10 gene USP24 is a negative regulator of autophagy and ULK1 protein stability
    Thayer, Julia A.
    Awad, Ola
    Hegdekar, Nivedita
    Sarkar, Chinmoy
    Tesfay, Henok
    Burt, Cameran
    Zeng, Xianmin
    Feldman, Ricardo A.
    Lipinski, Marta M.
    AUTOPHAGY, 2020, 16 (01) : 140 - 153
  • [25] Toripalimab: the First Domestic Anti-Tumor PD-1 Antibody in China
    Zhang, Lin
    Hao, Bo
    Geng, Zhihua
    Geng, Qing
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [26] SELECTIVE TARGETING OF GARP-LTGFß AXIS IN THE TUMOR MICROENVIRONMENT AUGMENTS PD-1 BLOCKADE VIA ENHANCING CD8+ T CELL ANTI-TUMOR IMMUNITY
    Li, Anqi
    Chang, Yuzhou
    Song, No-Joon
    Wu, Xingjun
    Chung, Dongjun
    Riesenberg, Brian
    Velegraki, Maria
    Kwon, Hyunwoo
    Chakravarthy, Karthik
    Bolyard, Chelsea
    Wang, Yi
    Ma, Qin
    Li, Zihai
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A876 - A876
  • [27] Anti-Tumor Potential of Post-Translational Modifications of PD-1
    Xi, Xiaoming
    Zhao, Wuli
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (03) : 2119 - 2132
  • [28] Targeting glycosylated PD-1 induces potent anti-tumor immunity
    Wang, Yuhan
    Sun, Linlin
    Yang, Riyao
    Liu, Jielin
    Qiu, Yufan
    Hsu, Jennifer L.
    Cha, Jong-ho
    Chan, Li-Chuan
    Hsu, Jung-Mao
    Lee, Heng-Huan
    Lai, Yun-Ju
    Khoo, Kay-Hooi
    Chung, Ezra M.
    Li, Chia-Wei
    Kim, Yong-Soo
    Park, Andrew H.
    Yang, Yi
    Yoo, Stephen S.
    Hung, Mien-Chie
    CANCER RESEARCH, 2020, 80 (16)
  • [29] Anti-tumor effects of genetic deletion of PD-1 in adult mice
    Raghavan, Sukaya
    Tovbis, Nataliya Shifrin
    Kochel, Christina
    Malefyt, Rene deWaal
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 339 - 340
  • [30] A novel anti-PD1-IL15 immunocytokine potentiates anti-tumor T cell activity of PD-1 checkpoint inhibition and IL-2R-beta-gamma agonism
    Lu, Dan
    Polonskaya, Zhanna
    Chang, Tzi-Pei
    Martomo, Stella
    Luna, Xenia
    Zhang, Zhikai
    Miyara, Faical
    Patel, Jeedar
    CANCER RESEARCH, 2020, 80 (16)
12345